-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the State Food and Drug Administration issued a notice, requiring the relevant production enterprises as soon as possible to the unique oral preparation instructions for revision. According to the results of the evaluation of adverse drug reactions, the Bureau requires that the monolithic oral preparation instructions should be labeled "" and other 6 types of adverse reactions, clearly "pregnant women prohibited."
Unique oral preparations include particles, softgels, chewing tablets, foam tablets, etc. , the effect of which is live blood pain relief, hemorrhage, more used after surgery knife and mouth pain bleeding, trauma fractures, rib sprains, pain, gum swelling and bleeding.
notification requirements, the drug description under the "adverse reactions" should be labeled the following 6 types of adverse reactions: stomach () discomfort and other indigestion system adverse reactions, pain, edema, allergies and other systemic adverse reactions, rashes, itching and other adverse skin reactions, dizziness, headache and other adverse neurological reactions, palpitations, chest tightness and other adverse reactions to the cardiovascular system, nose , cyanosis and other adverse reactions.
notice requirements, the drug instructions under the "taboo" must indicate that "pregnant women disabled" "allergic to this product or have a history of serious adverse reactions prohibited." "Precautions" should be noted under the "strictly in accordance with the drug instructions of the functional treatment and usage of the use of the current no children to apply this product of systematic research materials, not recommended for children to use, once the drug appears red, rash, itching, palpitations, chest tightness, aching gas, blood pressure decline or other symptoms related to serious adverse reactions, should immediately stop the drug and seek medical attention." (Health News)